Septerna, Inc. (SEPN) stock
SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30195% above fair value
$42.60+0.74 (+1.77%)
Close on Nov 13, 2026Market cap $1.99BP/E –Yield –
Septerna operating margin
Operating margin is operating income as a percentage of revenue.
Septerna's operating margin for the twelve months ending Sep 30, 2026 was -76.2%. For fiscal 2025 it was -148.6%, against -7518.4% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -148.6% | +7369.8 |
| FY2024 | Dec 31, 2024 | -7518.4% | −8892.6 |
| FY2023 | Dec 31, 2023 | 1374.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -144.2% | −156.4 |
| Q2 FY2026 | Jun 30, 2026 | -62.9% | +24288.3 |
| Q1 FY2026 | Mar 31, 2026 | -50.1% | +11780.9 |
| Q4 FY2025 | Dec 31, 2025 | -66.4% | +11593.0 |
| Q3 FY2025 | Sep 30, 2025 | 12.2% | +12824.7 |
| Q2 FY2025 | Jun 30, 2025 | -24351.3% | −19468.8 |
| Q1 FY2025 | Mar 31, 2025 | -11831.1% | −6944.6 |
| Q4 FY2024 | Dec 31, 2024 | -11659.4% | −40741.6 |
| Q3 FY2024 | Sep 30, 2024 | -12812.5% | +23672.3 |
| Q2 FY2024 | Jun 30, 2024 | -4882.4% | – |
| Q1 FY2024 | Mar 31, 2024 | -4886.4% | – |
| Q4 FY2023 | Dec 31, 2023 | 29082.2% | – |
| Q3 FY2023 | Sep 30, 2023 | -36484.8% | – |
See a number that looks wrong?